Retraction
mRNA-Modified FUS/NRF2 Signalling Inhibits Ferroptosis and Promotes Prostate Cancer Growth
Paper Information
Record ID:
47478
Author(s):
Publication Date:
August 05, 2022
Retraction Date:
June 28, 2023
(2.4 years years ago)
Subjects:
Specific Fields:
Biochemistry Biology - Cancer Genetics Medicine - Oncology Medicine - Urology/Nephrology
Biochemistry Biology - Cancer Genetics Medicine - Oncology Medicine - Urology/Nephrology
Institutions:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Hindawi
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (11)
11
Total Citations7
Post-Retraction(63.6%)
4
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
4
Within 1 year
0
After 2+ years
427
Days since retraction (latest)
Screening of tumor antigens and immunogenic cell death landscapes of prostate adenocarcinoma for exploration of mRNA vaccine
Guopeng Yu, Yuansheng Lin, Jianqing Wang et al. (14 authors)
Expert Review of Vaccines
Open Access
Published: Aug 2024
1 citation
1 citation
427 days after retraction
The Role of Methylation in Ferroptosis
Yushu Xie, Jie Xie, Liang Li
Journal of Cardiovascular Translational Research
Published: Jul 2024
1 citation
1 citation
397 days after retraction
Liquid–liquid phase separation in diseases
Xinyue Zhang, Yuan Lin, Wanlu Zhang et al. (8 authors)
MedComm
Open Access
Published: Jul 2024
9 citations
9 citations
369 days after retraction
Exosomal <scp>HSPB1</scp>, interacting with <scp>FUS</scp> protein, suppresses hypoxia‐induced ferroptosis in pancreatic cancer by stabilizing Nrf2 <scp>mRNA</scp> and repressing <scp>P450</scp>
Lun Zhang, Liuxu Yang, Keyuan Du
Journal of Cellular and Molecular Medicine
Open Access
Published: Apr 2024
5 citations
5 citations
306 days after retraction
Novel Insights into the Links between N6-Methyladenosine and Regulated Cell Death in Musculoskeletal Diseases
Juanjuan Han, C Wang, Haolin Yang et al. (6 authors)
Biomolecules
Open Access
Published: Apr 2024
4 citations
4 citations
301 days after retraction
Ferroptosis: a critical mechanism of N6-methyladenosine modification involved in carcinogenesis and tumor progression
Qingqing Wei, Changning Xue, Mengna Li et al. (11 authors)
Science China Life Sciences
Published: Feb 2024
5 citations
5 citations
245 days after retraction
The Regulation of Common Chinese Medicine Targeting Ferroptosis on a Variety of Clinical Diseases
Lanqing Li, Fanyu Fanyu, WANG Sailan et al. (7 authors)
Journal of Medical and Health Studies
Open Access
Published: Dec 2023
171 days after retraction
Uncovering the Secrets of Prostate Cancer’s Radiotherapy Resistance: Advances in Mechanism Research
Feng Lyu, Shiyu Shang, Xianshu Gao et al. (10 authors)
Biomedicines
Open Access
Published: Jun 2023
9 citations
9 citations
25 days before retraction
Mechanism of ferroptosis in traditional chinese medicine for clinical treatment: A review
Jiajiao Liu, Guanyin Jiang, Pengfei He et al. (6 authors)
Frontiers in Pharmacology
Open Access
Published: Jan 2023
12 citations
12 citations
175 days before retraction
LMNTD2-AS1 regulates immune cell infiltration and promotes prostate cancer progression by targeting FUS to regulate NRF2 signal pathway.
Haoming Wu, Ning Liu, Aifeng He et al. (8 authors)
PubMed
Published: Jan 2023
2 citations
2 citations
178 days before retraction
Retracted: mRNA‐Modified FUS/NRF2 Signalling Inhibits Ferroptosis and Promotes Prostate Cancer Growth
Computational and Mathematical Methods in Medicine
Computational and Mathematical Methods in Medicine
Open Access
Published: Jan 2023
178 days before retraction
Quick Stats
Total Citations:
11
Years Since Retraction:
2.4 years
Open Access:
Yes
Last Checked:
Jul 24, 2025